LANTHEUS HOLDINGS, INC.
LANTHEUS HOLDINGS, INC. is a federal contractor, registered under UEI XKLLNAJB6LJ6 and CAGE code 7ZG90. It has been awarded $379,822 across 3,757 federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.
Contact Information
Registration and classification details
Registration
UEI Code
XKLLNAJB6LJ6CAGE Code
7ZG90Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
Lanthue Holdings, Inc. operates as a specialized manufacturer within the pharmaceutical and medical chemical production sector, as indicated by its primary NAICS code 325412. The company focuses on the development and production of radiopharmaceuticals and other advanced therapeutic agents, leveragi...
Lanthue Holdings, Inc. operates as a specialized manufacturer within the pharmaceutical and medical chemical production sector, as indicated by its primary NAICS code 325412. The company focuses on the development and production of radiopharmaceuticals and other advanced therapeutic agents, leveraging precision chemistry, radiolabeling technologies, and GMP-compliant manufacturing processes. Its technical expertise includes the synthesis of complex molecular constructs, radioactive isotope handling, and closed-system aseptic processing to support diagnostic and therapeutic applications in nuclear medicine. The firm’s differentiation lies in its ability to scale small-batch, high-purity radiopharmaceutical production under stringent regulatory frameworks, ensuring consistency and safety for clinical use. No award history is available to infer specific agency relationships or contract patterns. Consequently, there is no demonstrable track record of direct engagement with federal agencies or government procurement programs based on the provided data. The company’s industry focus is centered on NAICS 325412, which encompasses the manufacturing of radiopharmaceuticals and other diagnostic imaging agents used in nuclear medicine. This vertical requires deep competency in radiochemistry, radiation safety, and FDA-regulated production protocols. Lanthue Holdings positions itself within the niche of advanced medical isotopes and targeted therapeutics, serving the clinical diagnostics and precision medicine markets through highly specialized manufacturing capabilities. As a 2L entity headquartered in North Billerica, Massachusetts, Lanthue Holdings, Inc. is structured as a small, technically focused manufacturer without public certifications. Its geographic presence is localized to its Massachusetts facility, suggesting a concentrated operational footprint aligned with biopharmaceutical innovation hubs in the Northeast. The company’s market positioning is defined by its technical specialization rather than broad government contracting experience.
Key Performance Metrics
Awards Count
All time
Active
Currently performing
Completed
Past period of performance
Total Awards
All time
Award Analytics & Distribution
Compete with LANTHEUS HOLDINGS, INC.
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for LANTHEUS HOLDINGS, INC.
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 650+ contractors already using CLEATUS
